Home Funds Aditya Birla Sun Life Pharma and Healthcare Fund-D

Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

Aditya Birla Sun Life · Sectoral
Very High
₹38.12
Current NAV
25 Jun 2026
41.4%
1Y Return
28.4%
3Y CAGR
25.4%
5Y CAGR
Watchlist
Analysis & Suitability
Pros / Upsides
  • Strong historical returns, outperforming category average in 3-year CAGR.
  • Highly cost-efficient with a low expense ratio of 0.64%.
  • Excellent risk-adjusted performance (Sharpe Ratio: 1.64).
  • Generates significant excess returns relative to benchmark index (Alpha: 4.64).
  • Very large asset base (AUM: ₹18,690 Cr) indicating high investor trust and liquidity.
Cons / Risks
  • Subject to high equity market volatility and short-term capital fluctuations.

Suitable for
  • Long-term wealth creation (5+ years horizon) like retirement or child education.
  • Systematic investments (SIP) for long-term target goal-based planning.
Not suitable for
  • Short-term goals (under 3 years) where preserving the capital is the main priority.
  • Short-term trading or speculative investment horizons.

Risk Profile: Very High Risk
Low Moderate High Very High
Risk Metrics
1.64
Sharpe Ratio
1.24
Beta
4.64
Alpha
2.20
Sortino
Fund Details
Fund House Aditya Birla Sun Life
Category Sectoral
AUM ₹18690 Cr
Expense Ratio 0.64%
Min SIP ₹500
Min Lumpsum ₹1000
Similar Funds in Sectoral
SBI Banking & Financial Services Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW)
SBI
₹39.84 44.9%
NIPPON INDIA EQUITY SAVINGS FUND - Direct Plan - IDCW Option
Nippon India
₹15.73 44.9%
Axis Fixed Maturity Plan - Series 129 (108 Days) - Regular Plan - IDCW
Axis
₹10.20 44.9%
ICICI Prudential Capital Protection Oriented Fund III - PLAN G - 60 Months - Direct Plan - Cumulative
ICICI Prudential
₹17.08 44.9%